Cargando…
Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection
BACKGROUND: Combination antiretroviral therapy has significantly advanced HIV-1 infection treatment. However, HIV-1 remains persistent in the brain; the inaccessibility of the blood–brain barrier allows for persistent HIV-1 infections and neuroinflammation. Nanotechnology-based drug carriers such as...
Autores principales: | Garcia, Caroline R, Rad, Armin T, Saeedinejad, Farnoosh, Manojkumar, Arvind, Roy, Deepa, Rodrigo, Hansapani, Chew, Sue Anne, Rahman, Ziyaur, Nieh, Mu-Ping, Roy, Upal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583757/ https://www.ncbi.nlm.nih.gov/pubmed/35642549 http://dx.doi.org/10.2217/nnm-2022-0043 |
Ejemplares similares
-
Differential expression of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) in Alzheimer's disease and HIV-1 associated neurocognitive disorders
por: Garces, Armando, et al.
Publicado: (2023) -
Tenofovir induced lichenoid drug eruption
por: Gupta, Mrinal, et al.
Publicado: (2015) -
Nanodisc-T(m): Rapid functional assessment of nanodisc reconstituted membrane proteins by CPM assay
por: Ashok, Yashwanth, et al.
Publicado: (2016) -
Polymer-Encased Nanodiscs and Polymer Nanodiscs: New Platforms for Membrane Protein Research and Applications
por: Chen, Angela, et al.
Publicado: (2020) -
Blaschkoid Lichenoid Drug Eruption Due to Tenofovir
por: Virath, Rekha, et al.
Publicado: (2020)